DOI QR코드

DOI QR Code

miR-18a-5p MicroRNA Increases Vascular Smooth Muscle Cell Differentiation by Downregulating Syndecan4

  • Kee, Hae Jin (Heart Research Center of Chonnam National University Hospital) ;
  • Kim, Gwi Ran (Heart Research Center of Chonnam National University Hospital) ;
  • Cho, Soo-Na (Heart Research Center of Chonnam National University Hospital) ;
  • Kwon, Jin-Sook (Division of Cardiovascular and Rare Diseases, Center for Biomedical Sciences, Korea National Institute of Health) ;
  • Ahn, Youngkeun (Heart Research Center of Chonnam National University Hospital) ;
  • Kook, Hyun (Department of Pharmacology and Medical Research Center for Gene Regulation, Chonnam National University Medical School) ;
  • Jeong, Myung Ho (Heart Research Center of Chonnam National University Hospital)
  • 투고 : 2014.03.05
  • 심사 : 2014.06.20
  • 발행 : 2014.04.30

초록

Background and Objectives: Differentiation and de-differentiation of vascular smooth muscle cells (VSMCs) are important events in atherosclerosis and restenosis after angioplasty. MicroRNAs are considered a key regulator in cellular processes such as differentiation, proliferation, and apoptosis. Here, we report the role of new miR-18a-5p microRNA and its downstream target genes in VSMCs and in a carotid balloon injury model. Materials and Methods: Expression of miR-18a-5p and its candidate genes was examined in VSMCs and in a carotid artery injury model by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and microRNA microarray analysis. VSMC differentiation marker genes including smooth muscle (SM) ${\alpha}-actin$ and $SM22{\alpha}$ were determined by Western blot, qRT-PCR, and a $SM22{\alpha}$ promoter study. Gene overexpression or knockdown was performed in VSMCs. Results: miR-18a-5p was upregulated in the rat carotid artery at the early time after balloon injury. Transfection of the miR-18a-5p mimic promoted the VSMC differentiation markers SM ${\alpha}-actin$ and $SM22{\alpha}$. In addition, miR-18a-5p expression was induced in differentiated VSMCs, whereas it decreased in de-differentiated VSMCs. We identified syndecan4 as a downstream target of miR-18-5p in VSMCs. Overexpression of syndecan4 decreased Smad2 expression, whereas knockdown of syndecan4 increased Smad2 expression in VSMCs. Finally, we showed that Smad2 induced the expression of VSMC differentiation marker genes in VSMCs. Conclusion: These results indicate that miR-18a-5p is involved in VSMC differentiation by targeting syndecan4.

키워드

과제정보

연구 과제 주관 기관 : Korean Society of Cardiology

참고문헌

  1. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:812-9. https://doi.org/10.1161/ATVBAHA.107.159327
  2. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801. https://doi.org/10.1152/physrev.00041.2003
  3. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5. https://doi.org/10.1038/nature02871
  4. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31. https://doi.org/10.1038/nrg1379
  5. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460:705-10.
  6. Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158-66. https://doi.org/10.1161/CIRCRESAHA.109.197517
  7. Li P, Zhu N, Yi B, et al. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 2013;113:1117-27. https://doi.org/10.1161/CIRCRESAHA.113.301306
  8. Leeper NJ, Raiesdana A, Kojima Y, et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011;226:1035-43. https://doi.org/10.1002/jcp.22422
  9. Torella D, Iaconetti C, Catalucci D, et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011;109:880-93. https://doi.org/10.1161/CIRCRESAHA.111.240150
  10. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009;284:3728-38. https://doi.org/10.1074/jbc.M808788200
  11. Choe N, Kwon JS, Kim JR, et al. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 2013;229:348-55. https://doi.org/10.1016/j.atherosclerosis.2013.05.009
  12. Friedman LM, Dror AA, Mor E, et al. MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. Proc Natl Acad Sci U S A 2009;106:7915-20. https://doi.org/10.1073/pnas.0812446106
  13. Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32. https://doi.org/10.1158/0008-5472.CAN-05-2352
  14. Ohgawara T, Kubota S, Kawaki H, et al. Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene. FEBS Lett 2009;583:1006-10. https://doi.org/10.1016/j.febslet.2009.02.025
  15. Kee HJ, Kwon JS, Shin S, Ahn Y, Jeong MH, Kook H. Trichostatin A prevents neointimal hyperplasia via activation of Kruppel like factor 4. Vascul Pharmacol 2011;55:127-34. https://doi.org/10.1016/j.vph.2011.07.001
  16. Kwon JS, Joung H, Kim YS, et al. Sulforaphane inhibits restenosis by suppressing inflammation and the proliferation of vascular smooth muscle cells. Atherosclerosis 2012;225:41-9. https://doi.org/10.1016/j.atherosclerosis.2012.07.040
  17. Ikesue M, Matsui Y, Ohta D, et al. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization. Arterioscler Thromb Vasc Biol 2011;31:1066-74. https://doi.org/10.1161/ATVBAHA.110.217703
  18. Matsui Y, Ikesue M, Danzaki K, et al. Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res 2011;108:1328-39. https://doi.org/10.1161/CIRCRESAHA.110.235689
  19. Herum KM, Lunde IG, Skrbic B, et al. Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J Mol Cell Cardiol 2013;54:73-81. https://doi.org/10.1016/j.yjmcc.2012.11.006
  20. Xie WB, Li Z, Shi N, et al. Smad2 and myocardin-related transcription factor B cooperatively regulate vascular smooth muscle differentiation from neural crest cells. Circ Res 2013;113:e76-86. https://doi.org/10.1161/CIRCRESAHA.113.301921

피인용 문헌

  1. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5 vol.27, pp.1, 2014, https://doi.org/10.1016/j.cellsig.2014.10.008
  2. Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 diabetes mellitus-associated erectile dysfunction vol.291, pp.6, 2014, https://doi.org/10.1007/s00438-016-1250-8
  3. Function, Role, and Clinical Application of MicroRNAs in Vascular Aging vol.2016, pp.None, 2014, https://doi.org/10.1155/2016/6021394
  4. Cordyceps bassiana inhibits smooth muscle cell proliferation via the ERK1/2 MAPK signaling pathway vol.21, pp.1, 2014, https://doi.org/10.1186/s11658-016-0023-z
  5. Dysregulation of hepatic microRNA expression profiles with C lonorchis sinensis infection vol.16, pp.None, 2014, https://doi.org/10.1186/s12879-016-2058-1
  6. The Role of MicroRNAs in Arterial Stiffness and Arterial Calcification. An Update and Review of the Literature vol.8, pp.None, 2014, https://doi.org/10.3389/fgene.2017.00209
  7. MicroRNA expression patterns in post-natal mouse skeletal muscle development vol.18, pp.None, 2014, https://doi.org/10.1186/s12864-016-3399-2
  8. The long noncoding RNA GAS5 negatively regulates the adipogenic differentiation of MSCs by modulating the miR-18a/CTGF axis as a ceRNA vol.9, pp.5, 2014, https://doi.org/10.1038/s41419-018-0627-5
  9. MiR-18a regulates myoblasts proliferation by targeting Fgf1 vol.13, pp.7, 2014, https://doi.org/10.1371/journal.pone.0201551
  10. The MicroRNA Family Both in Normal Development and in Different Diseases: The miR-17-92 Cluster vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/9450240
  11. Substantial Dysregulation of miRNA Passenger Strands Underlies the Vascular Response to Injury vol.8, pp.2, 2014, https://doi.org/10.3390/cells8020083
  12. Long non‐coding RNA SNHG16 regulates human aortic smooth muscle cell proliferation and migration via sponging miR‐205 and modulating Smad2 vol.23, pp.10, 2014, https://doi.org/10.1111/jcmm.14576
  13. 7-O-methylpunctatin, a Novel Homoisoflavonoid, Inhibits Phenotypic Switch of Human Arteriolar Smooth Muscle Cells vol.9, pp.11, 2014, https://doi.org/10.3390/biom9110716
  14. A functional polymorphism in the promoter of miR-17-92 cluster is associated with decreased risk of ischemic stroke vol.12, pp.1, 2014, https://doi.org/10.1186/s12920-019-0589-1
  15. Diagnostic and theranostic microRNAs in the pathogenesis of atherosclerosis vol.228, pp.1, 2014, https://doi.org/10.1111/apha.13353
  16. Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/7275246
  17. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension vol.257, pp.None, 2014, https://doi.org/10.1016/j.lfs.2020.117919
  18. Diagnostic and Prognostic Significance of serum miR-18a-5p in Patients with Atherosclerosis vol.27, pp.None, 2021, https://doi.org/10.1177/10760296211050642